Our Story

Current

Polysciences is thriving, advancing our capabilities, and investing in resources to meet evolving customer needs and leads into the future.

2024

Polysciences is recognized as SOCMA ChemStewards Safety Champions, completes a new lab suite buildout, and introduces a BSL-2 biolab, significantly enhancing research, development, and safety capabilities.

2023

Opens expansive Quality Control (QC) Lab, enhancing product testing and launches Kyfora Bio which is established as a standalone LLC in April 2024, advancing bioprocessing solutions for the biopharma and biotech industries.

2022

Finalizes buildout of advanced analytical lab & "The Exchange", a modern breakroom for collaboration and employee engagement.

2021

Polysciences celebrates 60 years of innovation, unifies legacy brands under Ethos Biosciences, and expands globally with the establishment of Ott Scientific Brasil & Ott Scientific India.

2019

Expands the commercial bioprocessing catalog, adds cleanroom space for production & packaging, and establishes dedicated production suites for GMP & non-GMP custom synthesis projects. Ott Scientific is formed as the parent organization.

2013

Achieves ISO 13485 Quality Management Certification. Polysciences is now FDA approved & SOCMA recognized.

2003-2005

Expands portfolio through the acquisition of Bangs Laboratories, Inc. (microsphere-based reagents & diagnostics), Dream Cosmetics (private-label cosmetics), and Dionis (consumer products).

1993

Michael Ott purchases Polysciences and established Polysciences Europe, GmbH, expanding their supply of specialized chemicals in Europe.

1979

Develops a large-scale process for isolating taxol, now used in treating solid tumor cancers.

1971

Polysciences publishes a catalog including Polymer Research, Life Sciences, Electron Microscopy, and Biomedical Applications sections.

1961

Polysciences, Inc. is established by B. David Halpern to supply ultrapure reagents for the electron microscopy market.